Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Tipo de estudio
Intervalo de año
1.
Braz. j. med. biol. res ; 44(6): 553-561, June 2011. ilus
Artículo en Inglés | LILACS | ID: lil-589973

RESUMEN

White matter injury characterized by damage to myelin is an important process in hypoxic-ischemic brain damage (HIBD). Because the oligodendrocyte-specific isoform of neurofascin, neurofascin 155 (NF155), and its association with lipid rafts are essential for the establishment and stabilization of the paranodal junction, which is required for tight interaction between myelin and axons, we analyzed the effect of monosialotetrahexosyl ganglioside (GM1) on NF155 expression and its association with lipid rafts after HIBD in Sprague-Dawley rats, weighing 12-15 g, on day 7 post-partum (P7; N = 20 per group). HIBD was induced on P7 and the rats were divided into two groups: one group received an intraperitoneal injection of 50 mg/kg GM1 three times and the other group an injection of saline. There was also a group of 20 sham-operated rats. After sacrifice, the brains of the rats were removed on P30 and studied by immunochemistry, SDS-PAGE, Western blot analysis, and electron microscopy. Staining showed that the saline group had definite rarefaction and fragmentation of brain myelin sheaths, whereas the GM1 group had no obvious structural changes. The GM1 group had 1.9-2.9-fold more GM1 in lipid rafts than the saline group (fraction 3-6; all P < 0.05) and 0.5-2.4-fold higher expression of NF155 in lipid rafts (fraction 3-5; all P < 0.05). Injection of GM1 increased the content of GM1 in lipid rafts as well as NF155 expression and its lipid raft association in HIBD rat brains. GM1 may repair the structure of lipid rafts, promote the association of NF155 (or other important proteins) with lipid rafts, stabilize the structure of paranodes, and eventually prevent myelin sheath damage, suggesting a novel mechanism for its neuroprotective properties.


Asunto(s)
Animales , Femenino , Masculino , Ratas , Moléculas de Adhesión Celular/metabolismo , Gangliósido G(M1)/metabolismo , Gangliósido G(M1)/farmacología , Hipoxia-Isquemia Encefálica/metabolismo , Lípidos de la Membrana/metabolismo , Vaina de Mielina/efectos de los fármacos , Factores de Crecimiento Nervioso/metabolismo , Animales Recién Nacidos , Western Blotting , Encéfalo/ultraestructura , Hipoxia-Isquemia Encefálica/patología , Inyecciones Intraperitoneales , Microscopía Electrónica , Vaina de Mielina/metabolismo , Vaina de Mielina/patología , Distribución Aleatoria , Ratas Sprague-Dawley
2.
Southeast Asian J Trop Med Public Health ; 1997 Dec; 28(4): 781-90
Artículo en Inglés | IMSEAR | ID: sea-31744

RESUMEN

Specific binding between bacterial cells and host tissue is an early step of the pathogenesis of infection. Burkholderia pseudomallei cells, the causative micro-organisms of melioidosis, were demonstrated to bind specifically to tissue glycolipids (asialo GM1 and asialo GM2) by solid phase binding assay on thin layer chromatograms. The detection limit was around 400 pmol of the glycolipids. Acid phosphatase purified from the culture filtrate of B. pseudomallei was tested for such binding properties, and the same results were obtained. According to our previous studies, the enzyme is a glycoprotein located on the cell surface, and hydrolysed tyrosine phosphate most actively among the substrates so far tested. The mode of binding between the enzyme and the glycolipids was analyzed by comparison of binding levels among three samples different in protein content, sugar content and specific phosphatase activities per protein and sugar residue. The results suggested the possibility of a receptor-ligand relationship between the bacterial enzyme and the host-cell glycolipids (asialo GM).


Asunto(s)
Fosfatasa Ácida/metabolismo , Burkholderia pseudomallei/enzimología , Gangliósido G(M1)/metabolismo , Gangliósidos , Glucolípidos/metabolismo , Glicoesfingolípidos/metabolismo , Humanos , Melioidosis/enzimología , Proteínas de la Membrana/metabolismo , Unión Proteica
3.
Arq. neuropsiquiatr ; 45(1): 60-6, mar. 1987. ilus
Artículo en Portugués | LILACS | ID: lil-39859

RESUMEN

Registro da observaçäo de um caso de gangliosidose GM1-tipo 1 (doença de Norman-Landing). O caso é típico, apresentando todos os principais sinais clínicos e biológicos da doença. O diagnóstico foi estabelecido pela demonstraçäo de déficit severo da atividade de beta-galactosidase em leucócitos, pela demonstraçäo de oligossacarídeos na urina e pelo exame histológico feito após a morte, que ocorreu antes de dois anos de idade, com comprometimento respiratório severo


Asunto(s)
Lactante , Humanos , Masculino , Gangliosidosis/patología , Corteza Cerebral/patología , Gangliósido G(M1)/metabolismo , Degeneración Nerviosa , Oligosacáridos/orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA